Upgrade to SI Premium - Free Trial

Context Therapeutics (CNTX)

0.36 +0.01 (2.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Context Therapeutics doses first patient in CT-202 Phase 1 trial September 9, 2026 7:30 AM - StreetInsider Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202 September 9, 2026 7:30 AM - StreetInsider Form SCHEDULE 13G/A Context Therapeutics Filed by: MPM BioImpact LLC August 14, 2026 4:07 PM - SEC Filing Form SCHEDULE 13G/A Context Therapeutics Filed by: Blue Owl Capital Holdings LP August 12, 2026 4:31 PM - SEC Filing Context Therapeutics Inc. (CNTX) Misses Q2 EPS by 6c August 6, 2026 2:45 AM - StreetInsider Form 8-K Context Therapeutics For: Aug 05 August 5, 2026 4:21 PM - SEC Filing Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress August 5, 2026 4:14 PM - Globe NewsWire Form 10-Q Context Therapeutics For: Jun 30 August 5, 2026 4:14 PM - SEC Filing Context Therapeutics gets Nasdaq minimum bid price deficiency notice July 31, 2026 4:11 PM - StreetInsider Form 8-K Context Therapeutics For: Jul 29 July 31, 2026 4:09 PM - SEC Filing Form SCHEDULE 13G/A Context Therapeutics Filed by: Octagon Capital Advisors LP July 31, 2026 4:01 PM - SEC Filing Form SCHEDULE 13G Context Therapeutics Filed by: BlackRock, Inc. July 27, 2026 4:27 PM - SEC Filing Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) July 10, 2026 4:05 PM - StreetInsider Context Therapeutics added to Russell 2000 and Russell 3000 indexes July 6, 2026 4:07 PM - StreetInsider Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes July 6, 2026 4:07 PM - Globe NewsWire Form 4 Context Therapeutics For: Jun 24 Filed by: Pasternak Andy June 26, 2026 4:24 PM - SEC Filing Form 4 Context Therapeutics For: Jun 24 Filed by: Stacey Jennifer Evans June 26, 2026 4:22 PM - SEC Filing Form 4 Context Therapeutics For: Jun 24 Filed by: West Linda June 26, 2026 4:21 PM - SEC Filing Form 4 Context Therapeutics For: Jun 24 Filed by: Smith Karen L. June 26, 2026 4:21 PM - SEC Filing Form 4 Context Therapeutics For: Jun 24 Filed by: Walker Luke Nathaniel June 26, 2026 4:20 PM - SEC Filing Form 4 Context Therapeutics For: Jun 24 Filed by: Kantoff Philip W. June 26, 2026 4:14 PM - SEC Filing Form 8-K Context Therapeutics For: Jun 24 June 26, 2026 4:08 PM - SEC Filing Full Article List